Form 4 for DLB Dolby Laboratories, Inc.
Accepted 2023-04-13 00:00:00 ET · period of report 2023-04-11 · accession 0001209191-23-024224 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2023-04-13 | 2023-04-11 | DLB | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $84.44 | -30.8K | 51.9K | -37% | -$2.60M |
| DI | 2023-04-13 | 2023-04-11 | DLB | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $45.50 | +30.8K | 82.7K | +59% | +$1.40M |
| DI | 2023-04-13 | 2023-04-11 | DLB | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $0.00 | -30.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-04-11 | S | D | 30,779 | $84.44 | 51,879 | I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 | — | — | (F1) The shares were sold in multiple transactions at prices ranging from $84.075 to $84.78. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| 2 | Common | Class A Common Stock | 2023-04-11 | M | A | 30,779 | $45.50 | 82,658 | I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2023-04-11 | M | D | 30,779 | $0.00 | 0 | I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 | $45.50 · — to 2023-12-15 | 30,779 Class A Common Stock | (F3) This performance-based stock option award was granted for a total of 97,199 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2019 was at 95% of target, or 92,339 shares. |